Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

completed350%
unknown233%
terminated117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
OTHER
Total Trials
6